Cargando…

HM71224, a novel Bruton’s tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis

BACKGROUND: Bruton’s tyrosine kinase (Btk) is critical for activation of B cells and myeloid cells. This study aimed to characterize the effects of HM71224, a novel Btk inhibitor, both in vitro and in a mouse model of experimental arthritis. METHODS: The kinase inhibition profile of HM71224 was anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jin Kyun, Byun, Joo-Yun, Park, Ji Ah, Kim, Yu-Yon, Lee, Ye Ji, Oh, Jeong In, Jang, Sun Young, Kim, Young Hoon, Song, Yeong Wook, Son, Jeewoong, Suh, Kwee Hyun, Lee, Young-Mi, Lee, Eun Bong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835877/
https://www.ncbi.nlm.nih.gov/pubmed/27090981
http://dx.doi.org/10.1186/s13075-016-0988-z
_version_ 1782427688504393728
author Park, Jin Kyun
Byun, Joo-Yun
Park, Ji Ah
Kim, Yu-Yon
Lee, Ye Ji
Oh, Jeong In
Jang, Sun Young
Kim, Young Hoon
Song, Yeong Wook
Son, Jeewoong
Suh, Kwee Hyun
Lee, Young-Mi
Lee, Eun Bong
author_facet Park, Jin Kyun
Byun, Joo-Yun
Park, Ji Ah
Kim, Yu-Yon
Lee, Ye Ji
Oh, Jeong In
Jang, Sun Young
Kim, Young Hoon
Song, Yeong Wook
Son, Jeewoong
Suh, Kwee Hyun
Lee, Young-Mi
Lee, Eun Bong
author_sort Park, Jin Kyun
collection PubMed
description BACKGROUND: Bruton’s tyrosine kinase (Btk) is critical for activation of B cells and myeloid cells. This study aimed to characterize the effects of HM71224, a novel Btk inhibitor, both in vitro and in a mouse model of experimental arthritis. METHODS: The kinase inhibition profile of HM71224 was analyzed. The in vitro effects of HM71224 on B cells and monocytes were analyzed by examining phosphorylation of Btk and its downstream signaling molecules, along with cytokine production and osteoclast formation. The in vivo effects of HM71224 were investigated in a mouse model of collagen-induced arthritis (CIA). RESULTS: HM71224 irreversibly bound to and inhibited Btk (IC(50) = 1.95 nM). The compound also inhibited the phosphorylation of Btk and its downstream molecules such as PLCγ2, in activated Ramos B lymphoma cells and primary human B cells in a dose-dependent manner. Furthermore, HM71224 effectively inhibited the production of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β by human monocytes, and osteoclast formation by human monocytes. Finally, HM71224 improved experimental arthritis and prevented joint destruction in a murine model of CIA. CONCLUSIONS: HM71224 inhibits Btk in B cells and monocytes and ameliorates experimental arthritis in a mouse model. Thus, HM71224 is a potential novel therapeutic agent for rheumatoid arthritis in humans. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-016-0988-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4835877
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48358772016-04-20 HM71224, a novel Bruton’s tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis Park, Jin Kyun Byun, Joo-Yun Park, Ji Ah Kim, Yu-Yon Lee, Ye Ji Oh, Jeong In Jang, Sun Young Kim, Young Hoon Song, Yeong Wook Son, Jeewoong Suh, Kwee Hyun Lee, Young-Mi Lee, Eun Bong Arthritis Res Ther Research Article BACKGROUND: Bruton’s tyrosine kinase (Btk) is critical for activation of B cells and myeloid cells. This study aimed to characterize the effects of HM71224, a novel Btk inhibitor, both in vitro and in a mouse model of experimental arthritis. METHODS: The kinase inhibition profile of HM71224 was analyzed. The in vitro effects of HM71224 on B cells and monocytes were analyzed by examining phosphorylation of Btk and its downstream signaling molecules, along with cytokine production and osteoclast formation. The in vivo effects of HM71224 were investigated in a mouse model of collagen-induced arthritis (CIA). RESULTS: HM71224 irreversibly bound to and inhibited Btk (IC(50) = 1.95 nM). The compound also inhibited the phosphorylation of Btk and its downstream molecules such as PLCγ2, in activated Ramos B lymphoma cells and primary human B cells in a dose-dependent manner. Furthermore, HM71224 effectively inhibited the production of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β by human monocytes, and osteoclast formation by human monocytes. Finally, HM71224 improved experimental arthritis and prevented joint destruction in a murine model of CIA. CONCLUSIONS: HM71224 inhibits Btk in B cells and monocytes and ameliorates experimental arthritis in a mouse model. Thus, HM71224 is a potential novel therapeutic agent for rheumatoid arthritis in humans. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-016-0988-z) contains supplementary material, which is available to authorized users. BioMed Central 2016-04-18 2016 /pmc/articles/PMC4835877/ /pubmed/27090981 http://dx.doi.org/10.1186/s13075-016-0988-z Text en © Park et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Park, Jin Kyun
Byun, Joo-Yun
Park, Ji Ah
Kim, Yu-Yon
Lee, Ye Ji
Oh, Jeong In
Jang, Sun Young
Kim, Young Hoon
Song, Yeong Wook
Son, Jeewoong
Suh, Kwee Hyun
Lee, Young-Mi
Lee, Eun Bong
HM71224, a novel Bruton’s tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis
title HM71224, a novel Bruton’s tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis
title_full HM71224, a novel Bruton’s tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis
title_fullStr HM71224, a novel Bruton’s tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis
title_full_unstemmed HM71224, a novel Bruton’s tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis
title_short HM71224, a novel Bruton’s tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis
title_sort hm71224, a novel bruton’s tyrosine kinase inhibitor, suppresses b cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835877/
https://www.ncbi.nlm.nih.gov/pubmed/27090981
http://dx.doi.org/10.1186/s13075-016-0988-z
work_keys_str_mv AT parkjinkyun hm71224anovelbrutonstyrosinekinaseinhibitorsuppressesbcellandmonocyteactivationandamelioratesarthritisinamousemodelapotentialdrugforrheumatoidarthritis
AT byunjooyun hm71224anovelbrutonstyrosinekinaseinhibitorsuppressesbcellandmonocyteactivationandamelioratesarthritisinamousemodelapotentialdrugforrheumatoidarthritis
AT parkjiah hm71224anovelbrutonstyrosinekinaseinhibitorsuppressesbcellandmonocyteactivationandamelioratesarthritisinamousemodelapotentialdrugforrheumatoidarthritis
AT kimyuyon hm71224anovelbrutonstyrosinekinaseinhibitorsuppressesbcellandmonocyteactivationandamelioratesarthritisinamousemodelapotentialdrugforrheumatoidarthritis
AT leeyeji hm71224anovelbrutonstyrosinekinaseinhibitorsuppressesbcellandmonocyteactivationandamelioratesarthritisinamousemodelapotentialdrugforrheumatoidarthritis
AT ohjeongin hm71224anovelbrutonstyrosinekinaseinhibitorsuppressesbcellandmonocyteactivationandamelioratesarthritisinamousemodelapotentialdrugforrheumatoidarthritis
AT jangsunyoung hm71224anovelbrutonstyrosinekinaseinhibitorsuppressesbcellandmonocyteactivationandamelioratesarthritisinamousemodelapotentialdrugforrheumatoidarthritis
AT kimyounghoon hm71224anovelbrutonstyrosinekinaseinhibitorsuppressesbcellandmonocyteactivationandamelioratesarthritisinamousemodelapotentialdrugforrheumatoidarthritis
AT songyeongwook hm71224anovelbrutonstyrosinekinaseinhibitorsuppressesbcellandmonocyteactivationandamelioratesarthritisinamousemodelapotentialdrugforrheumatoidarthritis
AT sonjeewoong hm71224anovelbrutonstyrosinekinaseinhibitorsuppressesbcellandmonocyteactivationandamelioratesarthritisinamousemodelapotentialdrugforrheumatoidarthritis
AT suhkweehyun hm71224anovelbrutonstyrosinekinaseinhibitorsuppressesbcellandmonocyteactivationandamelioratesarthritisinamousemodelapotentialdrugforrheumatoidarthritis
AT leeyoungmi hm71224anovelbrutonstyrosinekinaseinhibitorsuppressesbcellandmonocyteactivationandamelioratesarthritisinamousemodelapotentialdrugforrheumatoidarthritis
AT leeeunbong hm71224anovelbrutonstyrosinekinaseinhibitorsuppressesbcellandmonocyteactivationandamelioratesarthritisinamousemodelapotentialdrugforrheumatoidarthritis